Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pinter

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Experimental Dermatology|December 15, 2015
Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrestEva Maria Valesky, Igor Hrgovic, Monika Doll, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 3, 2019
[Gastrointestinal side effects of apremilast : Characterization and management]Andreas Pinter, Florian Beigel, Andreas Körber, et al.
Advances in Therapy|December 12, 2018
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician SurveyPeter Mohr, Sebastian Haferkamp, Andreas Pinter, et al.
The Journal of Dermatological Treatment|March 9, 2026
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 yearsPaolo Gisondi, Boni Elewski, Andreas Pinter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 7, 2024
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasisMatthias Augustin, Ulrich Mrowietz, Dagmar Willsmann-Theis, et al.
Dermatology and Therapy|September 23, 2023
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative ReviewTiago Torres, Jordi Galván, Nigel Crutchley, et al.
Experimental Dermatology|May 17, 2024
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in JapanYayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Nutrients|September 28, 2021
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical TrialAndreas Pinter, Peter Schwarz, Sascha Gerdes, et al.
Experimental Dermatology|January 20, 2022
Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativaIsabel Haferland, Chantal M Wallenwein, Tanja Ickelsheimer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2019
Topische Therapie bei Psoriasis vulgaris - ein BehandlungspfadAndreas Körber, Dagmar Wilsmann-Theis, Matthias Augustin, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Experimental Dermatology|December 15, 2015
Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrestEva Maria Valesky, Igor Hrgovic, Monika Doll, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 3, 2019
[Gastrointestinal side effects of apremilast : Characterization and management]Andreas Pinter, Florian Beigel, Andreas Körber, et al.
Advances in Therapy|December 12, 2018
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician SurveyPeter Mohr, Sebastian Haferkamp, Andreas Pinter, et al.
The Journal of Dermatological Treatment|March 9, 2026
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 yearsPaolo Gisondi, Boni Elewski, Andreas Pinter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 7, 2024
Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasisMatthias Augustin, Ulrich Mrowietz, Dagmar Willsmann-Theis, et al.
Dermatology and Therapy|September 23, 2023
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative ReviewTiago Torres, Jordi Galván, Nigel Crutchley, et al.
Experimental Dermatology|May 17, 2024
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in JapanYayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Nutrients|September 28, 2021
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical TrialAndreas Pinter, Peter Schwarz, Sascha Gerdes, et al.
Experimental Dermatology|January 20, 2022
Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativaIsabel Haferland, Chantal M Wallenwein, Tanja Ickelsheimer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2019
Topische Therapie bei Psoriasis vulgaris - ein BehandlungspfadAndreas Körber, Dagmar Wilsmann-Theis, Matthias Augustin, et al.
Pageof 14